Portfolio company
Coherus
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arcus Biosciences
This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.
SpringWorks Therapeutics
This biopharmaceutical company develops and commercialises targeted oncology medicines and therapies for patients with rare diseases and cancer.
Chimerix
This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.
Cullinan Oncology
This company develops therapies for patients living with autoimmune diseases and cancer.
Nuvation Bio
This biopharmaceutical company develops and commercialises targeted oncology therapies for patients with cancers that have unmet medical needs.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Asher Biotherapeutics
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
Calithera BioSciences
This biopharmaceutical company develops small-molecule drugs targeting tumor metabolism and immunology to treat patients with various forms of cancer.
